EUVIMED · CrossrefJournal
Cancer Communications
ISSN 2523-3548 · American Association for the Advancement of Science (AAAS)
Frequent topics
Hebei ProvinceXPC genecancer risk factorsesophageal squamous cell carcinomagastric cardia cancergene-environment interactiongenetic susceptibilitynucleotide excision repairsingle nucleotide polymorphismssmoking
Latest articles
Dissecting the dual pathways of colorectal cancer progression through spatial multi-omics
STAG2-Mediated Chromatin Organization Is Associated with Oncogenic Transcriptional Programs in Muscle-Invasive Bladder Cancer
MCT4-Dependent Lactate Signaling Is Linked to SPP1+ Tumor-Associated Macrophages in Papillary Thyroid Carcinoma
Neuronal Mimicry Features of Small Cell Lung Cancer Mediate Astrocyte-brain Metastasis Interactions and Highlight a Neurotrophic Therapeutic Target
Tumor cells Co-opt FGFBP2 to Evade Senescence in Lung Squamous Cell Carcinoma
Intratumoral Plasma Cells Orchestrate Early-Stage Lung Adenocarcinoma Evolution Through Prostaglandin E2-Induced Innate Immunity Impairment
High-risk HPV integration reprograms cis-regulatory architecture through HPV-specific stripe transcription factors
Targeting glycolytic GARP+ fibroblasts alleviates B cell-Th2 crosstalk-driven fibrosis in pancreatic adenocarcinoma
Gastric cancer burden in the Republic of Korea from 1990 to 2021: screening versus declining Helicobacter pylori prevalence
Prophylactic Cervical Lymphadenectomy Offers No Survival Benefit in the Surgical Management of Thoracic Esophageal Cancer: 10-Year Results of the ECTOP-2002 Randomized Controlled Trial
Association of Depth of Response with Survival After Immune Checkpoint Blockade in Advanced Melanoma
A Neural-Related Transcriptional Signature Is Associated with Reduced Immune Activity and Pathological Response to Neoadjuvant Chemo-Immunotherapy in Non-Small Cell Lung Cancer
The USP28/TFAP2A/MYC/SLC7A11 axis facilitates tumorigenesis by modulating ferroptosis and serves as a nanotherapeutic target in gemcitabine-resistant bladder cancer
Unraveling the Shaping of the Microenvironment in Brain Metastasis: From Dissemination to Overt Lesions
Effectiveness of Lung Cancer Screening by Sex and Tumor Histology: Extended, Pooled Analysis of the ITALUNG and LUSI Trials, with Comparison to Findings in the NLST
CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells
CEBPB-Regulated Gastric Cell Plasticity Promotes Liver Metastasis of Gastric Cancer
Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma
DKK1 Suppresses Hippo Signaling via PIP 3 –OGT–LRP6 O -GlcNAcylation in Hepatocellular Carcinoma
Harnessing the Power of CAR-NK Cells for Solid Tumors: Challenges, Innovations, and Future Frontiers in Immunotherapy
First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression
Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II Study
EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8 + T Cell Immunity
Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand–Ir(III) Complex Conjugates
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to Kras G12D Inhibition in Pancreatic Cancer
Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK- Positive Non-Small Cell Lung Cancer
Impact of China’s Drug Regulatory Reforms on the Development of Anti-Tumor Drugs
TGFBR1 *6A and Risk for Colorectal Cancer
Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences
Loss of WNT2B Increases Tumor Burden and Malignant Features in Colorectal Cancer
EUVIMED